Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (311-320 of 337) with videos related to

Pageof 34
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancerBoris Sepesi, Nicolas Zhou, William N William, et al.
Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2018
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i>-Mutant NSCLCXiuning Le, Sonam Puri, Marcelo V Negrao, et al.
British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Cancer|July 10, 2019
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised miceYungchang Chen, Ran Zhang, Li Wang, et al.
Cancer Letters|December 3, 2014
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancerChuncheng Hao, Li Wang, Shaohua Peng, et al.
Cancer Research|May 25, 2013
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersXifeng Wu, Liang Wang, Yuanqing Ye, et al.
Journal for Immunotherapy of Cancer|February 3, 2022
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytesParin Shah, Marie-Andrée Forget, Meredith L Frank, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Pageof 34

Showing results (311-320 of 337) with videos related to

Sort By:
Pageof 34
Lung Cancer (Amsterdam, Netherlands)|January 17, 2022
Surgical approach does not influence changes in circulating immune cell populations following lung cancer resectionNathaniel Deboever, Daniel J McGrail, Younghee Lee, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 22, 2022
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancerBoris Sepesi, Nicolas Zhou, William N William, et al.
Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2018
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i>-Mutant NSCLCXiuning Le, Sonam Puri, Marcelo V Negrao, et al.
British Journal of Cancer|December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trialYusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Cancer|July 10, 2019
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised miceYungchang Chen, Ran Zhang, Li Wang, et al.
Cancer Letters|December 3, 2014
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancerChuncheng Hao, Li Wang, Shaohua Peng, et al.
Cancer Research|May 25, 2013
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersXifeng Wu, Liang Wang, Yuanqing Ye, et al.
Journal for Immunotherapy of Cancer|February 3, 2022
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytesParin Shah, Marie-Andrée Forget, Meredith L Frank, et al.
The Lancet. Oncology|May 19, 2015
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsJoe Y Chang, Suresh Senan, Marinus A Paul, et al.
Pageof 34